These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29964219)

  • 21. Expression of gut-homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?
    Abad-Fernández M; Gutiérrez C; Madrid N; Hernández-Novoa B; Díaz L; Muñoz-Fernández MA; Moreno S; Vallejo A
    HIV Med; 2015 Jan; 16(1):15-23. PubMed ID: 24831847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of HIV-1 virions to α4β 7 expressing cells and impact of antagonizing α4β 7 on HIV-1 infection of primary CD4+ T cells.
    Li C; Jin W; Du T; Wu B; Liu Y; Shattock RJ; Hu Q
    Virol Sin; 2014 Dec; 29(6):381-92. PubMed ID: 25527342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of αEβ7 integrin suppresses accumulation of CD8
    Zundler S; Schillinger D; Fischer A; Atreya R; López-Posadas R; Watson A; Neufert C; Atreya I; Neurath MF
    Gut; 2017 Nov; 66(11):1936-1948. PubMed ID: 27543429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection.
    Shacklett BL; Cox CA; Sandberg JK; Stollman NH; Jacobson MA; Nixon DF
    J Virol; 2003 May; 77(10):5621-31. PubMed ID: 12719554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrin α4β7 in HIV-1 infection: A critical review.
    Liu Q; Lusso P
    J Leukoc Biol; 2020 Aug; 108(2):627-632. PubMed ID: 32272507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals.
    Uzzan M; Tokuyama M; Rosenstein AK; Tomescu C; SahBandar IN; Ko HM; Leyre L; Chokola A; Kaplan-Lewis E; Rodriguez G; Seki A; Corley MJ; Aberg J; La Porte A; Park EY; Ueno H; Oikonomou I; Doron I; Iliev ID; Chen BK; Lui J; Schacker TW; Furtado GC; Lira SA; Colombel JF; Horowitz A; Lim JK; Chomont N; Rahman AH; Montaner LJ; Ndhlovu LC; Mehandru S
    Sci Transl Med; 2018 Oct; 10(461):. PubMed ID: 30282696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoic acid imprints gut-homing specificity on T cells.
    Iwata M; Hirakiyama A; Eshima Y; Kagechika H; Kato C; Song SY
    Immunity; 2004 Oct; 21(4):527-38. PubMed ID: 15485630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoic acid imprints a mucosal-like phenotype on dendritic cells with an increased ability to fuel HIV-1 infection.
    Guerra-Pérez N; Frank I; Veglia F; Aravantinou M; Goode D; Blanchard JL; Gettie A; Robbiani M; Martinelli E
    J Immunol; 2015 Mar; 194(5):2415-23. PubMed ID: 25624458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.
    Clayton R; Ohagen A; Nicol F; Del Vecchio AM; Jonckers TH; Goethals O; Van Loock M; Michiels L; Grigsby J; Xu Z; Zhang YP; Gutshall LL; Cunningham M; Jiang H; Bola S; Sarisky RT; Hertogs K
    Antiviral Res; 2009 Nov; 84(2):142-9. PubMed ID: 19699239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa.
    Cimbro R; Vassena L; Arthos J; Cicala C; Kehrl JH; Park C; Sereti I; Lederman MM; Fauci AS; Lusso P
    Blood; 2012 Sep; 120(13):2610-9. PubMed ID: 22896005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transporters for Antiretroviral Drugs in Colorectal CD4+ T Cells and Circulating α4β7 Integrin CD4+ T Cells: Implications for HIV Microbicides.
    Mukhopadhya I; Murray GI; Duncan L; Yuecel R; Shattock R; Kelly C; Iannelli F; Pozzi G; El-Omar EM; Hold GL; Hijazi K
    Mol Pharm; 2016 Sep; 13(9):3334-40. PubMed ID: 27467446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conservation of the α4β7 lymphocyte homing receptor in HIV-infected patients with distinct transmission routes and disease progression profiles.
    Hait SH; Darc M; Machado ES; Soares EA; Sprinz E; Soares MA
    AIDS Res Hum Retroviruses; 2014 May; 30(5):493-7. PubMed ID: 24387749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo.
    Fischer A; Zundler S; Atreya R; Rath T; Voskens C; Hirschmann S; López-Posadas R; Watson A; Becker C; Schuler G; Neufert C; Atreya I; Neurath MF
    Gut; 2016 Oct; 65(10):1642-64. PubMed ID: 26209553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy.
    Gao Y; Kraft JC; Yu D; Ho RJY
    Eur J Pharm Biopharm; 2019 May; 138():75-91. PubMed ID: 29678735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrarectal immunization and IgA antibody-secreting cell homing to the small intestine.
    Agnello D; Denimal D; Lavaux A; Blondeau-Germe L; Lu B; Gerard NP; Gerard C; Pothier P
    J Immunol; 2013 May; 190(9):4836-47. PubMed ID: 23547118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut-homing Δ42PD1
    Cheung AKL; Kwok HY; Huang Y; Chen M; Mo Y; Wu X; Lam KS; Kong HK; Lau TCK; Zhou J; Li J; Cheng L; Kiat Lee B; Peng Q; Lu X; An M; Wang H; Shang H; Zhou B; Wu H; Xu A; Yuen KY; Chen Z
    Nat Microbiol; 2017 Oct; 2(10):1389-1402. PubMed ID: 28808299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging HIV-1 resistance to tipranavir and darunavir in patients with virological failure to first-generation protease inhibitors in Taiwan.
    Hsieh SM; Chang SY; Hung CC; Sheng WH; Chen MY; Chang SC
    Int J STD AIDS; 2011 Nov; 22(11):617-20. PubMed ID: 22096044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Cell Internalizing Antibody Targeting Capsid Protein (p24) Inhibits the Replication of HIV-1 in T Cells Lines and PBMCs: A Proof of Concept Study.
    Ali SA; Teow SY; Omar TC; Khoo AS; Choon TS; Yusoff NM
    PLoS One; 2016; 11(1):e0145986. PubMed ID: 26741963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Major influence of CD4 count at the initiation of cART on viral and immunological reservoir constitution in HIV-1 infected patients.
    Depincé-Berger AE; Vergnon-Miszczycha D; Girard A; Frésard A; Botelho-Nevers E; Lambert C; Del Tedesco E; Genin C; Pozzetto B; Lucht F; Roblin X; Bourlet T; Paul S
    Retrovirology; 2016 Jun; 13(1):44. PubMed ID: 27363286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The memory B cell subset responsible for the secretory IgA response and protective humoral immunity to rotavirus expresses the intestinal homing receptor, alpha4beta7.
    Williams MB; Rosé JR; Rott LS; Franco MA; Greenberg HB; Butcher EC
    J Immunol; 1998 Oct; 161(8):4227-35. PubMed ID: 9780197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.